Quofenix 300 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
7680672390017
CH-67239
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Associated product:
QUOFENIX subst sèche 300 mg flac 10 pce
Fiches Amavita / Sun Store / Coop Vitality
Article details
- Package size
- 10 x 300
- Selling units
- 10
- Measure
- mg
- Galenic form
- Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
delafloxacinum
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
delafloxacinum megluminum
|
- | Substance | WIZUS |
|
megluminum
|
- | Substance | HNIDK |
|
sulfobutylbetadexum natricum
|
2.4 G | Substance | HBESI |
|
dinatrii edetas
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
acidum hydrochloridum
|
- | Substance | HNIDK |
|
natrium
|
175.0 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 697.85
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/12/2021
Authorization holder
A. Menarini GmbH
8050 Zürich
Authorization information
- Swissmedic authorization number
- 67239
- Drug name
- Quofenix, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- PULPI
- ATC Code
- J01MA23
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 28/05/2020
- Authorization expiration date
- 31/12/9999
- IT Number
- 08.01.8.
- Domain
- Human medicine
Package details
- Description (FR)
- QUOFENIX subst sèche 300 mg flac 10 pce
- Description (DE)
- QUOFENIX Trockensub 300 mg Durchstf 10 Stk
- Market launch
- 28/05/2020
- Narcotic (BTM)
- No